InvestorsHub Logo
Followers 7
Posts 299
Boards Moderated 0
Alias Born 01/07/2010

Re: None

Wednesday, 01/16/2019 6:26:08 PM

Wednesday, January 16, 2019 6:26:08 PM

Post# of 469764
OT United Neuroscience "cautiously optimistic" about Alzheimers synthetic peptide vax candidate UB-311 after ph 2a study achieves 96% response rate w/good safety profile, suggesting early clinical findings "reproducible"; CEO Hu not looking to develop “one-shot wonder"

Needs looking into. First time I'm hearing about this & don't know MOA
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News